These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9015274)

  • 21. Purification of IgG against ribonucleoprotein by a homemade immunoaffinity chromatography column for rabies diagnosis.
    da Silva Santos JH; da Silva GH; Iamamoto K; Katz ISS; Guedes F; Fernandes ER; de Cassia Rodrigues da Silva A; Dos Ramos Silva S
    J Immunol Methods; 2019 Aug; 471():1-10. PubMed ID: 30904384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The influence of N-linked glycosylation on the antigenicity and immunogenicity of rubella virus E1 glycoprotein.
    Qiu Z; Tufaro F; Gillam S
    Virology; 1992 Oct; 190(2):876-81. PubMed ID: 1381541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analyses of disulfides present in the rubella virus E1 glycoprotein.
    Gros C; Linder M; Wengler G; Wengler G
    Virology; 1997 Apr; 230(2):179-86. PubMed ID: 9143273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preparation of immunoblot test stripes from a Rubella virus-like particles dye crystal complex as antigen.
    Giessauf A; Flaim M; Walder G; Dierich MP; Würzner R
    Arch Virol; 2005 Oct; 150(10):2077-90. PubMed ID: 15868096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation of highly purified human cytomegalovirus envelope antigen.
    Hudecz F; Gonczol E; Plotkin SA
    Vaccine; 1985 Sep; 3(3):300-4. PubMed ID: 2998113
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A recombinant rubella virus E1 glycoprotein as a rubella vaccine candidate.
    Perrenoud G; Messerli F; Thierry AC; Beltraminelli N; Cousin P; Fasel N; Vallet V; Demotz S; Duchosal MA; Moulon C
    Vaccine; 2004 Dec; 23(4):480-8. PubMed ID: 15530696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cellular and humoral immune responses to rubella virus structural proteins E1, E2, and C.
    Chaye HH; Mauracher CA; Tingle AJ; Gillam S
    J Clin Microbiol; 1992 Sep; 30(9):2323-9. PubMed ID: 1383269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Double antibody sandwich ELISA for the detection of rubella virus antigen.
    Komatsu H; Suzuki Y; Matumoto M
    Kitasato Arch Exp Med; 1992 Apr; 65(1):23-31. PubMed ID: 1336082
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A recombinant envelope protein from Dengue virus purified by IMAC is bioequivalent with its immune-affinity chromatography purified counterpart.
    Hermida L; Rodríguez R; Lazo L; López C; Márquez G; Páez R; Suárez C; Espinosa R; García J; Guzmán G; Guillén G
    J Biotechnol; 2002 Mar; 94(2):213-6. PubMed ID: 11796173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Virus-like particles as a source for obtaining antigens for diagnosing rubella].
    Alekseev SB; Butenko AM; Gaĭdamovich SIa; Larichev VF; Pustovoĭt BV; Tkachenko AV; Zaĭtsev IZ
    Vopr Virusol; 2001; 46(1):37-41. PubMed ID: 11233286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Eupergit C as a carrier for high-performance liquid chromatographic-based immunopurification of antigens and antibodies.
    Fleminger G; Wolf T; Hadas E; Solomon B
    J Chromatogr; 1990 Jun; 510():311-9. PubMed ID: 2401703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure of rubella E1 glycoprotein epitopes established by multiple peptide synthesis.
    Lozzi L; Rustici M; Corti M; Cusi MG; Valensin PE; Bracci L; Santucci A; Soldani P; Spreafico A; Neri P
    Arch Virol; 1990; 110(3-4):271-6. PubMed ID: 1690535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Presence of a neutralizing domain in isolates of rubella virus in Cordoba, Argentina.
    Cordoba P; Grutadauria SL; Cuffini C; Zapata MT
    Clin Diagn Lab Immunol; 1997 Jul; 4(4):493-5. PubMed ID: 9220172
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A complement-dependent neutralizing monoclonal antibody against glycoprotein II of pseudorabies virus.
    Nakamura T; Ihara T; Nagata T; Ishihama A; Ueda S
    Vet Microbiol; 1990 Aug; 24(2):193-8. PubMed ID: 2173250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reactivity of a recombinant rubella E1 antigen expressed in E. coli.
    Londesborough P; Terry G; Ho-Terry L
    Arch Virol; 1992; 122(3-4):391-7. PubMed ID: 1731700
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunoaffinity purification of two major proteins of bovine leukemia virus (gp51 and p24) and their use for discrimination between vaccinated and infected animals.
    Merza M; Sundquist B; Söber J; Morein B
    J Virol Methods; 1991 Aug; 33(3):345-53. PubMed ID: 1723735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Semliki Forest virus vectors expressing the H and HN genes of measles and mumps viruses reduce immunity induced by the envelope protein genes of rubella virus.
    Callagy SJ; Kelly BJ; Fleeton MN; Sheahan BJ; Galbraith SE; Atkins GJ
    Vaccine; 2007 Oct; 25(43):7481-90. PubMed ID: 17905485
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative and qualitative assay of rubella IgA antibody in breast milk.
    Hayakawa Y; Zhou Y; Mizuguchi M; Frey TK; Ushijima H
    J Med Virol; 2010 Aug; 82(8):1475-9. PubMed ID: 20572092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Significance of avidity and immunoblot analysis for rubella IgM-positive serum samples in pregnant women.
    Hofmann J; Liebert UG
    J Virol Methods; 2005 Dec; 130(1-2):66-71. PubMed ID: 16024097
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design of a chimaeric antigen and its use in the detection of IgG antibodies against rubella virus.
    Xing W; Li L; Zhang J; Ma C; Xue X; Ye S; Xue H; Hu R; Ma Y; Yuan H
    Virol J; 2022 Feb; 19(1):33. PubMed ID: 35197095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.